Sickle Cell Disease by V. Tran, N. Archer | OPENPediatrics

By the end of this video, the learner will be able to describe the fundamental elements of sickle cell disease, including pathophysiology, potential complications, and management strategies.
0:00 Introduction
3:18 Pathophysiology
5:06 Complications
9:13 Management
15:13 Summary
LEARNING OBJECTIVES
By the end of this video, the learner will be able to:
• Describe the fundamental elements of sickle cell disease
• Discuss the pathophysiology of sickle cell disease
• Identify the common complications seen in this condition
• Describe the management options for sickle cell disease and its complications
AUTHORS
Virginia Tran, BS
Harvard Medical School
Natasha Archer, MD
Physician
Dana Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics
Harvard Medical School
DATES
Initial publication: June 9, 2023
A multilingual transcript is available for this video, thanks to the generous support of our community members who volunteered their time to translate our content. Learn more about our OPENPediatrics translation campaign here: www.openpediatrics.org/conten...
Please visit: www.openpediatrics.org

OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open-access and thus at no expense to the user.
For further information on how to enroll, please email: [e-mail]
Please note: OPENPediatrics does not support nor control any related videos in the sidebar, these are placed by KZbin. We apologize for any inconvenience this may cause.
CITATION
Tran V, Callas C, Moulton H, Fantasia K, McFee AM, Wolbrink TA, Archer N. Sickle Cell Disease. 06/2023. OPENPediatrics. • Sickle Cell Disease by... .

[@DrMohamedAyyedi]

Very common in Tunisia 🇹🇳🇹🇳🌶️🌶️

[@Rene-uz3eb]

6:45 a higher calcium diet in rats delayed hypertrophy. Bp medication made it worse. Careful though: large intake will result in more urinary calcium, effected by calcitonin, and the precalcitonin levels are used to diagnose serious infections. So calcium intake right before a blood test should be avoided

[@teanikahoffman1189]

Please stop telling providers the genotype HbSC is “ milder” by the time a person reaches adulthood it all becomes severe

[@Praise_ye_Yahweh]

I find the video very helpful, but the mutation occurs on the 11th chromosome, not the 6th chromosome.

[@rukayarasheed5421]

Its 6 chromosome not 11

[@Praise_ye_Yahweh]

​@@rukayarasheed5421I don't know everything, but I see the 11th in what I have read, if it would be easy for you, could you please provide me a source to check? Here are some sources that state the 11th: www.genome.gov/Genetic-Disorders/Sickle-Cell-Disease#:~:text=Sickle%20cell%20disease%20is%20caused,and%20glide%20through%20blood%20vessels. www.cdc.gov/genomics/about/basics.htm